Showing results (491-500 of 686) with videos related to
Sort By:
Pageof 69
Journal of the National Cancer Institute|December 18, 1991
Human IgM monoclonal antibody 16.88: pharmacokinetics and immunogenicity in colorectal cancer patientsH J Haisma, H M Pinedo, M A Kessel, et al.European Journal of Cancer & Clinical Oncology|October 1, 1987
Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma GroupH T Mouridsen, L Bastholt, R Somers, et al.Revista De Neurologia|June 9, 2007
[Impact of warning against procrastination of thrombolysis in ischemic stroke]J F Maestre-Moreno, C Arnáiz-Urrutia, P del Saz-Saucedo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2008
Preoperative [18F] FDG-PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathologyJ Emmering, N C Krak, J J M Van der Hoeven, et al.Cytometry|January 1, 1992
Quantification by laser scan microscopy of intracellular doxorubicin distributionJ H de Lange, N W Schipper, G J Schuurhuis, et al.British Journal of Cancer|June 11, 1999
Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell linesC J van Moorsel, H M Pinedo, G Veerman, et al.Molecular Pharmacology|July 23, 2004
Sulfasalazine down-regulates the expression of the angiogenic factors platelet-derived endothelial cell growth factor/thymidine phosphorylase and interleukin-8 in human monocytic-macrophage THP1 and U937 cellsMichiel de Bruin, Godefridus J Peters, Ruud Oerlemans, et al.Cancer Investigation|January 1, 1995
Taxanes: a new class of antitumor agentsM T Huizing, V H Misser, R C Pieters, et al.Biochimica Et Biophysica Acta|March 4, 2000
Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell linesC J van Moorsel, A M Bergman, G Veerman, et al.Cancer Research|June 11, 1999
Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2J H Hooijberg, H J Broxterman, M Kool, et al.Pageof 69